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ABSTRACT
Objective Accurate gestational-age (GA) estima-
tion, preferably by ultrasound measurement of fetal
crown–rump length before 14weeks’ gestation, is an
important component of high-quality antenatal care. The
objective of this study was to determine how GA can
best be estimated by fetal ultrasound for women who
present for the first time late in pregnancy with uncertain
or unknown menstrual dates.
Methods INTERGROWTH-21st was a large, prospec-
tive, multicenter, population-based project performed in
eight geographically defined urban populations. One of
its principal components, the Fetal Growth Longitudi-
nal Study, aimed to develop international fetal growth
standards. Each participant had their certain menstrual
dates confirmed by first-trimester ultrasound examina-
tion. Fetal head circumference (HC), biparietal diameter
(BPD), occipitofrontal diameter (OFD), abdominal cir-
cumference (AC) and femur length (FL) were measured
every 5weeks from 14weeks’ gestation until delivery.
For each participant, a single, randomly selected ultra-
sound examination was used to explore all candidate
biometric variables and permutations to build models
to predict GA. Regression equations were ranked based
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upon minimization of the mean prediction error, good-
ness of fit and model complexity. An automated machine
learning algorithm, the Genetic Algorithm, was adapted
to evaluate>64 000 potential polynomial equations as
predictors.
Results Of the 4607 eligible women, 4321 (94%) had
a pregnancy without major complications and delivered
a live singleton without congenital malformations. After
other exclusions (missing measurements in GA window
and outliers), the final sample comprised 4229 women.
Two skeletal measures, HC and FL, produced the best GA
prediction, given by the equation loge(GA)= 0.03243×
(loge(HC))2 + 0.001644×FL× loge(HC)+ 3.813. When
FL was not available, the best equation based on
HC alone was loge(GA)=0.05970× (loge(HC))2 +
0.000000006409× (HC)3 + 3.3258. The estimated
uncertainty of GA prediction (half width 95% interval)
was 6–7 days at 14weeks’ gestation, 12–14 days at
26weeks’ gestation and > 14days in the third trimester.
The addition of FL to the HC model led to improved
prediction intervals compared with using HC alone, but
no further improvement in prediction was afforded by
adding AC, BPD or OFD. Equations that included other
measurements (BPD, OFD and AC) did not perform
better.
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Conclusions Among women initiating antenatal care late
in pregnancy, a single set of ultrasound measurements
combining HC and FL in the second trimester can
be used to estimate GA with reasonable accuracy. We
recommend this tool for underserved populations but
considerable efforts should be implemented to improve
early initiation of antenatal care worldwide. © 2016
The Authors. Ultrasound in Obstetrics & Gynecology
published by John Wiley & Sons Ltd on behalf of the
International Society of Ultrasound in Obstetrics and
Gynecology.
INTRODUCTION
Reliable estimation of gestational age (GA) is essential
as it allows appropriate scheduling of a woman’s
antenatal care, informs obstetric management decisions
and facilitates the correct interpretation of fetal growth
assessment1. Abnormal fetal growth patterns such as
growth restriction or macrosomia may be missed or
diagnosed incorrectly if GA is unknown or incorrect.
Reliable GA estimation is also important at a popu-
lation level to calculate rates of preterm delivery and
small-for-gestational-age neonates at delivery. The lack
of accurate GA estimation, particularly in geographical
regions at greatest risk of these conditions, means that
preterm delivery and small-for-gestational-age rates are
mere approximations in many parts of the world2,3.
Traditionally, GA is estimated using the first day of the
last menstrual period (LMP), which assumes that ovula-
tion occurs on day 14 of the menstrual cycle. Irregular
menses, unknown or uncertain dates, oral contraceptive
use or recent pregnancy or breastfeeding, issues that occur
in a large proportion of women, may all influence the accu-
racy of this method4–6. In such cases, early (< 14 weeks’
gestation) ultrasound measurement of fetal crown–rump
length (CRL) is recommended7,8. First-trimester GA
assessment is more accurate than is dating in late preg-
nancy because, with advancing gestation, fetal ultrasound
measurements have a larger absolute error9 and growth
disturbances become more noticeable, resulting in poten-
tial underestimation of GA for an abnormally small fetus
and overestimation for a macrosomic fetus.
Unfortunately, in many settings in which high-risk
pregnancies are prevalent, women attend their first
antenatal care visit late in pregnancy or even at the
time of delivery. This makes it difficult to manage
complications, evaluate fetal growth and implement
evidence-based interventions, such as the administration
of corticosteroids for fetal lung maturation in cases of
threatened preterm labor.
The present analysis of the Fetal Growth Longitudinal
Study (FGLS), one of the main components of the
INTERGROWTH-21st Project, aimed to complement our
previous work of early GA estimation by ultrasound
measurement of CRL10. We explored a set of equations to
estimate GA using fetal biometric measurements acquired
during a single ultrasound scan performed between 14
and 34 weeks’ gestation.
SUBJECTS AND METHODS
INTERGROWTH-21st was a multicenter, multiethnic,
population-based project, conducted between 2009 and
2014 in eight countries11. Its primary aim was to
study growth, health, nutrition and neurodevelopment
from< 14 weeks’ gestation to 2 years of age, using
the same conceptual framework as that of the WHO
Multicentre Growth Reference Study12,13.
Eight urban areas located at low altitude (≤ 1600 m)
were chosen as study sites, within which we selected
all institutions that provided pregnancy and intrapartum
care and at which> 80% of deliveries occurred. Women
receiving antenatal care had to plan to deliver in these
institutions or in a similar hospital located in the same
geographical area and there had to be an absence
or low levels of major, known, non-microbiological
contamination such as pollution, domestic smoke,
radiation or any other toxic substances14.
Women from these populations with a singleton
pregnancy that was conceived naturally and who met the
individual inclusion criteria were recruited prospectively
and consecutively into the FGLS. The study methods have
been described in detail elsewhere11,15.
The true GA (GAtrue) was defined by the woman’s LMP
determined at the first visit at< 14 + 0 weeks’ gestation,
provided that: (i) the date was certain; (ii) she had a regular
24–32-day menstrual cycle; (iii) she had not been using
hormonal contraception or breastfeeding in the preceding
2 months; and (iv) it was in agreement (within 7 days) with
the measurement of fetal CRL at 9 + 0 to 13 + 6 weeks’
gestation15.
The same type of ultrasound machine (HD-9; Philips
Ultrasound, Bothell, WA, USA) with curvilinear abdomi-
nal transducers (C5-2, C6-3, V7-3) was used for all fetal
measurements at ≥ 14 + 0 weeks’ gestation. To reduce
expected value bias, the ultrasound machines were spe-
cially adapted so that the measurements were not visible
on the screen. However, as women presented for their
first visit at different clinics within the geographical area,
for those ultrasound scans performed at< 14 + 0 weeks’
gestation (CRL measurements only), it was considered
acceptable to use other, locally available machines, pro-
vided that they were evaluated and approved by the
study team. All sonographers (n= 39) at the eight study
sites underwent rigorous training and standardization.
In accordance with the protocol, CRL and other fetal
biometry measures were assessed for quality; the for-
mer were also reviewed blindly by our collaborators at
the Socie´te´ Franc¸aise pour l’Ame´lioration des Pratiques
Echographiques16,17.
Women were invited for follow-up ultrasound scans
every 5 weeks (within 1 week either side) after the
initial dating scan, so that the possible ranges after
the dating scan were: 14–18, 19–23, 24–28, 29–33,
34–38 and 39–42 weeks’ gestation. At each visit, fetal
head circumference (HC), biparietal diameter (BPD),
occipitofrontal diameter (OFD), abdominal circumference
(AC) and femur length (FL) were measured three times
© 2016 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd Ultrasound Obstet Gynecol 2016; 48: 719–726.
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from three separately obtained ultrasound images of each
structure18.
Head measurements were taken in an axial view at the
level of the thalami, with an angle of insonation as close
as possible to 90◦. The head had to be oval in shape,
symmetrical, centrally positioned and filling at least 30%
of the monitor. The midline echo (representing the falx
cerebri) had to be broken anteriorly, at one-third of its
length, by the cavum septi pellucidi. The thalami had to
be located symmetrically on either side of the midline.
Calipers were then placed on the outer border (‘outer to
outer’) of the parietal bones at the widest or longest part
of the skull for the BPD and OFD, respectively; the HC
was measured using the ellipse facility of the ultrasound
machine on the outer border of the skull.
The measurements of the fetal abdomen were taken in a
cross-sectional view (as close as possible to a circle), with
the umbilical vein in the anterior third of the abdomen
(at the level of the portal sinus) and the stomach bubble
visible. The operator was instructed to avoid applying
too much pressure with the transducer as this can distort
the circular shape of the fetal abdomen. The abdomen
had to fill at least 30% of the monitor screen; the spine
preferably had to be positioned at either 3 or 9 o’clock to
avoid internal shadowing; and the kidneys and bladder
did not have to be visible. For the measurements, the
contour of the ellipse was placed on the outer border of
the abdomen.
Finally, the FL was measured using a longitudinal view
of the fetal thigh closest to the probe and with the femur
as close as possible to the horizontal plane. The angle of
insonation of the ultrasound beam was approximately 90◦
with the full length of the bone visualized, unobscured by
shadowing from adjacent bony parts, and the femur had
to fill at least 30% of the monitor screen. The intersection
of the calipers was placed on the outer borders of the
edges of the femoral diaphysis (outer to outer) ensuring
clear femoral edges.
Detailed measurement protocols, standardization pro-
cedures and quality-control methods employed across all
sites are described in detail elsewhere15,19–21.
Statistical analysis
For each woman included in the study, a single ultrasound
scan between 14 + 0 and 40 + 0 weeks’ gestation was
selected randomly using the ‘sample’ function in Stata
(version 13). At each scan, the routinely measured
fetal biometric variables were recorded. To overcome
the problem of data truncation at the lower end of
gestation (<14 + 0 weeks), we followed the approach
described previously and applied to CRL data22. Using
the international fetal growth equations for HC, AC,
FL, BPD and OFD18, we simulated 20 observations for
each day between 12 + 0 and 13 + 6 weeks’ gestation
(n= 280), which is approximately the same number of
observations for each day of GA in the untruncated
dataset. After simulation, we restricted the data based
on HC by excluding values< 85 mm or> 330 mm and
visually inspecting a plot of the data to assess whether
the truncation problem had been overcome. Using
the augmented dataset, fractional polynomial regression
analyses were employed, using the Xrigls function in Stata,
to model the mean and SD of GA for each biometric
variable22.
In order to establish the relationship of fetal biometric
variables and GA we used an automated machine learning
‘Genetic Algorithm’ (Appendix S1). This method was
chosen because a more traditional fractional polynomial
approach, which is well-suited to modeling a single
variable, has limited scope when used with multiple
biometric variables that are highly correlated. By virtue
of the automated approach, the Genetic Algorithm is
able to evaluate large numbers (in this case> 64 000)
of potential combinations of biometric variables that
are used to build polynomial equations as predictors
of GA, which would not be feasible using conventional
approaches. By specifying a mathematical definition
of optimal performance, based upon minimization of
the mean prediction error (root mean squared error
(RMSE)), the first stage of model development was entirely
automated with the capacity to assemble, evaluate and
modify equations. We were therefore able to use the data
themselves to generate preliminary models in an entirely
objective manner.
Briefly, a large number of preliminary candidate
equations were developed using combinations of all
candidate biometric variables (including powers (0.5, 1,
2 and 3), their logs and their products). Each of the
candidate equations was used to obtain for each fetus a
predicted GA (GApredicted) as an estimate of their GAtrue.
After preliminary analysis it was clear that the GApredicted
values were not normally distributed; this was addressed
by predicting the natural logarithm of GApredicted. The
equations were then ranked to assess which had the
lowest uncertainty based on the 95% prediction interval.
We used a four-step approach to determine our
final equation (see Appendix S1 for more detailed
explanation).
(1) Equation discovery using the Genetic Algorithm. The
automated Genetic Algorithm was used to determine
the equation providing the best prediction of GA using
combinations of fetal biometric variables. Briefly,
the model initiated itself by assigning polynomial
equations linking fetal biometry within the dataset
and GAtrue. Model terms, coefficients and powers
were selected randomly within specified limits. Once
defined, the individual equations were each used
to predict GAtrue using the observed fetal biometry
data. The performance of individual equations was
measured by calculating the RMSE between the
GAtrue and GApredicted at each iteration of the Genetic
Algorithm. For each combination of biometric
variables, the equation with the lowest RMSE was
selected automatically and modified by methods
that mimic the genetic principles of mutation and
crossover. Thus, a second generation of equations
© 2016 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd Ultrasound Obstet Gynecol 2016; 48: 719–726.
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was developed with the ‘positive predictive qualities’
of the first generation preserved in their structure.
Furthermore, random variation was introduced as
‘mutations’ into the best-performing equations in
order to assess whether such mutations conferred an
advantage in prediction, evaluated using the RMSE.
By repeating the process over many iterations, the
structure of equations was continuously refined until
there was convergence upon the equation, or series of
equations, that most accurately predicted GAtrue. All
data processing at this stage was performed using the
‘GAPolyfitn’ function in MATLAB version R2014b.
(2) Goodness of fit. Visual inspection of scatter plots
was used to compare GAtrue with GApredicted for
each candidate equation obtained from the Genetic
Algorithm. Quantile–quantile (QQ) plots were used
to compare the distributions. Well-fitting models were
identified by a QQ plot with minimal deviation
from the line of equality. For each equation,
absolute residuals between GAtrue − GApredicted were
regressed on GA using fractional polynomial methods
(powers ± 0.5, 1, 2 and 3) to provide an equation that
approximated the SD, and multiplied by a constant
to estimate the 2.5th and 97.5th centiles using the
Xrigls function in Stata23. The goodness of fit of
these estimated SDs was assessed by calculating the
proportion of GApredicted that were outside the 95%
prediction intervals (± 1.96 SD), which should be 5%.
(3) Evaluation of model complexity. To facilitate a
suitable balance between parsimony and model
performance, estimates of Akaike’s information
criterion (AIC)24 were calculated and compared. The
AIC combines an estimate of the goodness of fit of a
model with a penalty for increasing model complexity.
In addition, candidate equations with similar indices
were compared in terms of number of terms and
complexity, defined as the sum of the powers of
each variable. Where two equations demonstrated
similar performance, the equation with a less complex
structure was preferred.
(4) Postproduction model refinement. After examining
the model complexity, it appeared that most of the
contribution to the prediction of GA was based on
HC. Therefore, simplified models were constructed,
restricted to biometry of the fetal head (HC, OFD
and BPD).
The INTERGROWTH-21st Project was approved by
the Oxfordshire Research Ethics Committee ‘C’ (ref:
08/H0606/139), the research ethics committees of the
individual participating institutions, as well as the
corresponding regional health authorities in which the
project was implemented.
RESULTS
Of the 4607 women recruited into the FGLS, 4321
delivered live singletons without congenital mal-
formations (Figure 1). Women with missing fetal
Excluded (n = 78):
 Miscarriage, termination or stillbirth
Enrolled in FGLS
(n = 4607)
Pregnancy and delivery
data available
(n = 4500)
Live births
(n = 4422)
Live births without congenital
malformation
(n = 4321)
Excluded (n = 107):
 Lost to follow-up or withdrew
 consent (n = 71)
 Severe maternal disorder (n = 29)
 Smoker (n = 6)
 Recreational drug user (n = 1)
At least one eligible scan between
14 and 40 weeks’ gestation
(n = 4229)
Excluded (n = 101):
 Congenital malformation
Excluded (n = 92):
 No fetal measurements (n = 84)
 Outlier measurements* (n = 7)
 Fetal HC > 330 mm (n = 1)
Figure 1 Flowchart of recruitment of women with singleton
pregnancy to the Fetal Growth Longitudinal Study (FGLS). *>5 SD
above or below mean fetal measurement. HC, head circumference.
Table 1 Maternal and pregnancy characteristics of 4229 women
enrolled in Fetal Growth Longitudinal Study of the
INTERGROWTH-21st Project who had a singleton live delivery
Characteristic Value
Maternal age (years) 27.8 ± 3.8
Maternal height (cm) 162.2 ± 5.8
Maternal weight (kg) 61.5 ± 9.2
Maternal BMI (kg/m2) 23.2 ± 3.0
GA at first visit (weeks) 11.3 ± 1.4
Nulliparous 2815 (66.6)
Pre-eclampsia 31 (<1)
Preterm delivery (< 37 weeks’ gestation) 189 (4.5)
Birth weight (kg)* 3.3 ± 0.4
Birth weight<2500 g* 127 (3.1)
Newborn sex male 2101 (49.7)
Data are given as mean ± SD or n (%). Maternal baseline charac-
teristics were measured at<14 weeks’ gestation. *≥ 37 weeks’
gestation only. BMI, body mass index; GA, gestational age.
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Table 2 Equations for estimating gestational age (GA) and its SD in late pregnancy, derived from biometric data of 4229 singleton
pregnancies
Equation
Variables in
equation (mm) Equation to estimate logeGApredicted (days) Equation to estimate SD of GApredicted (days)
1 HC 0.05970 × (loge(HC))2 + 0.000000006409 × (HC)3 + 3.3258 0.6492 × (GA × 0.01)3 + 2.991
2 HC, FL 0.03243 × (loge(HC))2 + 0.001644 × FL × loge(HC) + 3.813 0.04009 × GA – 1.149
FL, femur length (in mm); HC, head circumference (in mm); loge, natural logarithm.
measurements (n= 84), and outliers defined as fetal
measurements> 5 SD above/below the mean (n= 7)
were excluded. We further restricted the actual data at
the top end by excluding HC values> 330 mm (n= 1),
resulting in a total of 4229 women who contributed
a single, randomly selected ultrasound scan between
14 + 0 and 40 + 0 weeks’ gestation (Figure 1). Of the
280 observations simulated and added to actual data,
we similarly excluded HC values< 85 mm (n= 148) and
obtained a final analysis sample of 4361 observations.
The baseline characteristics and perinatal events of
the study population (n= 4229 excluding simulated
observations) are shown in Table 1.
The equations that best estimated GAtrue based on low-
est RMSE, best fit and optimal AIC are shown in Table 2.
The equations selected were based on HC alone and a
combination of HC and FL; despite including multiple
measures (HC, BPD, OFD, AC and FL) in the models,
only HC and FL were retained after the selection process.
As an example, to calculate GA using
Equation 1, if HC is 250 mm, median GA =
exp [0.05970 × (loge(250))2 + 0.000000006409 × (250)3
+3.3258] = exp [5.245986506] = 189.8 days (equivalent
to 27.1 weeks). To calculate GA using Equation 2,
if HC is 250 mm and FL is 55 mm, median
GA = exp [0.03243 × (loge(250))2 + 0.001644 × 55 × loge
(250) + 3.813] = exp [5.300929] = 200.5 days (equivalent
to 28.6 weeks).
Using equations of the median and SD one can
easily compute any desired centiles using the relation
Pth centile = median + KSD, where K is the normal
equivalent deviate (z-score) corresponding to a par-
ticular centile, e.g. K = 1.88 for the 97th centile and
−1.88 for the 3rd centile. The SDs in this equation
are the predicted estimates from the regression
analysis. For example, the 3rd centile for
GA = exp (0.05970 × (loge(HC))2 + 0.000000006409 ×
(HC)3 + 3.3258) + (−1.88 × (0.6492 × (median GA ×
0.01)3 + 2.991)).
Overall, based on a model using HC only, the uncer-
tainty of estimated GA gradually increased with advancing
GA, from 6–7 days in either direction at 14 + 0 weeks’
gestation to 15–20 days at 32 + 0 weeks’ gestation
(Table 3). Inclusion of FL led to an improvement in
the accuracy of prediction throughout gestation of about
1–6 days. Inclusion of the other parameters led to no fur-
ther improvement and therefore these were not included in
the equations resulting from the Genetic Algorithm search.
Table 3 Characteristics of goodness of fit of an equation based on
fetal head circumference (HC) (Equation 1) and an equation based
on fetal HC and femur length (FL) (Equation 2) for predicting
gestational age (GA) in late pregnancy
Equation
Characteristic 1 2
Variables in equation HC HC, FL
RMSE (log days) 0.0423 0.0352
R2 0.98 0.99
Goodness of fit (%)* 5.21 6.20
AIC 16.33 14.69
Variation (days) around mean
GA estimate† at:
14 weeks 7.1 5.4
16 weeks 7.7 6.5
18 weeks 8.4 7.6
20 weeks 9.4 8.7
22 weeks 10.5 9.8
24 weeks 11.9 10.9
26 weeks 13.5 12.0
28 weeks 15.4 13.2
30 weeks 17.6 14.3
32 weeks 20.1 15.4
34 weeks 23.0 16.5
*Percentage of predicted estimates of GA outside 95% prediction
interval across all GA. †Half width of 95% prediction interval.
AIC, Akaike’s information criterion; RMSE, root mean squared
error.
The plots of GApredicted vs GAtrue between 14 + 0 and
34 + 0 weeks’ gestation demonstrated good model fitting
(Figure 2 for the scatterplots and Figures S1 and S2 for
the QQ plots).
Apart from estimating the most likely GA (by using
GApredicted for a set of measurements), we also present
the lower and upper bounds of the estimation of GA
(Table S1). The lower bound can be used in clinical
management for women who present in late pregnancy; it
is an estimate of the likely ‘least GA’, e.g. they are 97.5%
likely to be at least X weeks.
DISCUSSION
Main findings
We have shown that a single set of basic ultrasound
measurements of HC and FL in the second trimester can
be used to estimate GA with reasonable accuracy. The
estimation is best at lower GAs where the 95% prediction
interval is within 6 days, whereas it is just over 12 days at
© 2016 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd Ultrasound Obstet Gynecol 2016; 48: 719–726.
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Figure 2 Scatterplots showing predicted gestational age (GA) based on fetal head circumference (a) and on fetal head circumference and
femur length (b) at 14 to 34 weeks of true GA. Solid line is line of equality and dashed lines are ± 2 SD.
26 + 0 weeks’ gestation. The addition of FL to HC leads
to considerable improvement over just using HC, but no
further improvement in prediction is afforded by adding
AC, BPD or OFD.
Strengths and weaknesses
We have produced equations for GA assessment that are
more precise than those used currently in routine clinical
practice (Table 4). This may be due to the prospective
nature of the study, a large sample size, accurately dated
pregnancies, a clearly defined measurement protocol,
quality control measures and a statistical approach
that searched for the optimal combination of factors
iteratively, rather than relying upon a user-controlled
search. The multicenter, international setting of the
study with measurements taken by a large group of
sonographers provides external validity.
There is an intrinsic limitation when estimating GA
by fetal anthropometric-based equations, i.e. that the
measurement is of fetal size not GA. Fetal size may vary for
reasons other than differences in GA, especially as factors
conditioning abnormal fetal growth are more prevalent in
the populations among which the equation is most likely
to be used. In other words, it is important to take into
account the impact of pathology (fetal growth restriction
and overgrowth) on GA estimation. This is true for any
equation estimating GA; the accuracy at an individual
level will depend on the ‘normality’ of the fetal size and,
at the population level, on the prevalence of abnormal
growth patterns. Thus, efforts should focus on modifying
health systems and referral pathways to prevent late
presentation in pregnancy, rather than simply achieving
technological advances in fetal size-based dating.
Interpretation
Ultrasound assessment of GA is performed assuming that
fetal size can be used as a proxy for GA. This assumption
depends on: (i) the GA at which biometry is performed
(at earlier GAs growth is more uniform and there is
less measurable growth impairment); (ii) the choice of
biometric variable; (iii) accuracy of the measurement,
which is affected by technical aspects of imaging and
operator skill; and (iv) absence of pathology that could
affect growth.
The most accurate way to estimate GA is by
measuring fetal CRL between 8 + 0 and 14 + 0 weeks’
gestation, which is associated with a 95% prediction
interval of 2.7 days10,25. This method is the basis
of recommended pregnancy-dating policies throughout
much of the developed world26. Beyond 14 + 0 weeks’
gestation, fetal flexion limits the accuracy of CRL
measurements for dating purposes and GA estimates are
based on measurement of the HC, BPD, AC and FL or a
combination of these8,27.
Our results demonstrate the relative inaccuracy of
late GA assessment, which is due to the increasing
biological variability in fetal size as well as the increasing
absolute error of fetal measurements with advancing GA9.
Therefore, all information (clinical and imaging) should
be considered when dating pregnancies and providing
obstetric care, particularly after late pregnancy dating.
Thus, we recommend that the following principles should
be applied in clinical practice.
(1) Assessment of fetal age should be based on the earliest
available ultrasound measurement after 8 + 0 weeks’
gestation, provided that the measurements are
technically adequate. CRL should be used before
14 + 0 weeks’ gestation and Equation 2 (HC and
FL) after 14 + 0 but before 26 + 0 weeks’ gestation.
Equation 1 can be used in settings in which only HC
is available.
(2) If menstrual dates are reliable and within the
prediction limits of the fetal measurement, ultrasound
examination should merely confirm the GA assessed
by LMP.
© 2016 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd Ultrasound Obstet Gynecol 2016; 48: 719–726.
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Table 4 Commonly used pregnancy-dating equations and their imprecision in estimating gestational age (GA) (half width of 95% prediction
intervals)
Imprecision in GA estimation (days) for assessment at:
Reference R2 12–18weeks 18–24weeks 24–30weeks 30–36weeks
Hadlock et al. (1984)29
BPD 0.967 8.3 12.1 15.3 21.6
HC 0.973 8.3 10.4 14.4 20.9
AC 0.969 11.6 14.4 15.3 20.7
FL 0.971 9.7 12.6 14.6 20.7
HC + BPD 0.974 7.6 10.4 13.9 20.0
HC + FL 0.976 8.4 10.6 13.9 18.8
HC + AC 0.98 7.6 9.4 13.0 17.6
HC + FL + BPD 0.981 7.3 9.5 12.7 17.6
HC + AC + FL 0.981 8.0 10.2 13.2 17.6
HC + BPD + AC + FL 0.981 7.6 9.8 12.6 17.1
Altman and Chitty (1997)30
HC NR 8.0 13.0 17.0 22.0
AC, abdominal circumference; BPD, biparietal diameter; FL, femur length; HC, head circumference; NR, not reported.
(3) When menstrual dates are reliable and fall outside
the prediction interval of ultrasound assessment there
are two interpretations: the menstrual dates are in
fact incorrect and GA should be based on ultrasound
measurement, or the GA is correct as assessed by LMP
and the fetus is an abnormal size for that GA (or both).
Clinical features of growth restriction, e.g. reduced
amniotic fluid or abnormal uterine or umbilical artery
blood flow, should be taken into consideration, as
should factors that may lead to overgrowth, e.g.
maternal diabetes. An interval ultrasound scan should
then be carried out to confirm GA.
(4) When menstrual dates are unknown, GA estimation
should be based on ultrasound examination, which
has reasonable accuracy until 26 + 0 weeks’ gestation,
and a further ultrasound scan should be carried out.
Finally, when GA is estimated in the third trimester,
the possible error is large and must be taken into account
to ensure safe obstetric practice. The use of the concept
of a ‘minimum’ GA, by using the lower limit of the
prediction interval from the equation can be useful
in this instance (Table S1). For example, if a woman
presents with threatened preterm labor and the ultrasound
examination suggests a median GA of 34 + 6 weeks
based on HC and FL, it should be appreciated that
the GA could be as low as 32 + 6 weeks, i.e. it is most
likely that the GA is 34 + 6 weeks, but we are 95%
certain that the GA is at least 32 + 6 weeks. However,
if the fetus is growth restricted, the GA could be as
much as 36 + 5 weeks. This analysis is very relevant
to clinical decision making, e.g. when administering
prophylactic corticosteroids or transferring a neonate to
a higher level of care. In contrast, labor induction may
be considered at 40 + 0 weeks’ gestation based on late
assessment, as the GA could be more advanced. Such
a clinically cautious approach is particularly important
as it is known that unreliable reporting of LMP and late
antenatal care are both associated with adverse pregnancy
outcome5,28.
Conclusion
We have shown that a single set of ultrasound
measurements in the second trimester can be used to
estimate GA with relative accuracy. We recommend these
tools for the management of women who present late
in pregnancy. However, we strongly encourage, as a
priority, the promotion of early antenatal care in regions
and subpopulations that are not yet benefiting from this
practice.
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